VAERS Explorer
Back to explore

Report #2865415

Received Oct 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (3)

ErythemaPyrexiaSkin erosion

Symptom narrative

chest became red raw; Fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of erythema in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced erythema (Verbatim: chest became red raw) and fever (Verbatim: Fever). The outcome of the erythema and fever were not reported. The reporter considered the erythema and fever to be related to Shingrix. The company considered the erythema and fever to be related to Shingrix. Additional Information: GSK Receipt Date: 01-OCT-2025 This case was reported by a patient via interactive digital media. The patient received Shingrix vaccine and had an extremely bad reaction. The chest became red raw and had a fever. The patient refused the follow up shot. The batch number was not provided and we and unable to contact the reporter.